Andrew D Zelenetz

Featured in: Favicon

nature.com Favicon

thelancet.com Favicon

bloodjournal.org Favicon

onclive.com Favicon

targetedonc.com Favicon

valuebasedcancer.com Favicon

oncpracticemanagement.com Favicon

onlinelibrary.wiley.com

Articles

Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma

Oct 31, 2023 | pericles.pericles-prod.literatumonline.com | Robert Stuver |Ariela Noy |Santosha A. Vardhana |Andrew D Zelenetz

Alison J. Moskowitz Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Weill Cornell Medical College, New York, New York, USASearch for more papers by this author
Gemcitabine plus pembrolizumab after checkpoint blockade failure as a strategy in multiply relapsed Hodgkin lymphoma

Oct 31, 2023 | onlinelibrary.wiley.com | Robert Stuver |Ariela Noy |Santosha A. Vardhana |Andrew D Zelenetz

Alison J. Moskowitz Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA Weill Cornell Medical College, New York, New York, USASearch for more papers by this author

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →